Metabolic Syndrome: Risk Factors And Predictors Among Adults In Saudi Arabia | 36246
ISSN: 2165-7904

Journal of Obesity & Weight Loss Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Metabolic syndrome: Risk factors and predictors among adults in Saudi Arabia

3rd International Conference and Exhibition on Obesity & Weight Management

Naji Aljohani

KSAU-HS, Saudi Arabia

ScientificTracks Abstracts-Workshop: J Obes Weight Loss Ther

DOI: 10.4172/2165-7904.C1.020

Background: Metabolic Syndrome (MetS) is a cluster of established cardiovascular risk factors that collectively increase predisposition to major chronic diseases including heart diseases and diabetes mellitus. Citizens of developing countries such as Saudi Arabia are at risk for MetS secondary to industrialization and accessibility to fast foods. In this epidemiologic study, the kingdom-wide prevalence of MetS is determined. Methods: A total of 4578 Saudis aged 15-64 were randomly selected from 20 regions all over Saudi Arabia. Anthropometrics were collected and fasting blood samples collected ascertaining fasting blood glucose and lipid profile. Components of full MetS as defined by the International Diabetes Federation (IDF) were used for screening. Results: The over-all prevalence of MetS is 28.3%. Males had a significantly higher prevalence than females (31.4 versus 25.2%; p=0.001). Prevalence of MetS showed a parallel increase with age, and inversely with educational status as well as income. Region also played a significant contributor to MetS. Conclusion: Despite accumulating evidence of an epidemic, MetS remains largely unresolved in the kingdom. Aggressive pubic campaign and policies should be implemented to control future damage of MetS in the kingdom.

Naji Aljohani, MD, ABIM, FRCP, is an endocrinologist consultant and assistant professor at the Specialized Diabetes and Endocrine Center, Faculty of Medicine in King Fahad Medical City, King Saud bin Abdulaziz University for Health Sciences in Riyadh, Saudi Arabia. He is also a board member of the Prince Mutaib Chair for Biomarkers of Osteoporosis in King Saud University, Riyadh, Saudi Arabia, the Saudi Society of Endocrinology and Metabolism and Director of Diabetes Prevention in the Saudi Diabetes Association. He obtained his fellowship at the University of Manitoba, Winnipeg, Canada and thyroid fellowship at University of Toronto, Canada. He has authored/co-authored several peer-reviewed papers and has been an invited speaker in both national and international conferences in the fields of endocrinology, obesity and vitamin D.

Email: [email protected]